Physician profile
Adam Nelson
NPI 1609219229
$7,418.55
in general payments reported to CMS, 2019-2025
14 companies · $1,675 in 2025
The $1,675 reported for 2025 was more than what 77% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $150 · 2021: $160 · 2022: $75.61 · 2023: $115 · 2024: $3,767 · 2025: $1,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,144 · Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,144.41 |
| Food and Beverage | $413.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,190.38 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $1,475.12 | 2019 | |
| Atricure, INC. | $168.25 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Depuy Synthes Sales INC. | $134.21 | 2021 | |
| Ethicon US, LLC | $114.49 | 2020 | |
| Kls-Martin L.P. | $86.85 | 2020-2025 | |
| Integra Lifesciences Corporation | $69.15 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $50.58 | 2024 | |
| Stryker Corporation | $28.94 | 2025 | 1788, Spy-Phi System |
| Kerecis Limited | $25.75 | 2021 | |
| La Jolla Pharmaceutical Company | $21.23 | 2023 | Xerava |
| Smith+Nephew, INC. | $20.94 | 2022 | |
| Medtronic, INC. | $19.93 | 2023 | Aquamantys(Tm) |
| Davol INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.